Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics

In the field of nuclear medicine, the β⁺ -emitting ⁴³Sc and β⁻ -emitting ⁴⁷Sc are promising candidates in cancer diagnosis and targeted radionuclide therapy (TRT) due to their favorable decay schema and shared pharmacokinetics as a true theranostic pair. A...

Description complète

Détails bibliographiques

Auteurs principaux:	Jason P. Meier, Hannah J. Zhang, Richard Freifelder, Mohammed Bhuiyan, Phillip Selman, Megan Mendez, Pavithra H. A. Kankanamalage, Thomas Brossard, Antonino Pusateri, Hsiu-Ming Tsai, Lara Leoni, Sagada Penano, Kaustab Ghosh, Brittany A. Broder, Erica Markiewicz, Amy Renne, Walter Stadler, Ralph Weichselbaum, Jerry Nolen, Chien-Min Kao, Satish K. Chitneni, David A. Rotsch, Russell Z. Szmulewitz, Chin-Tu Chen
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-08-01
Collection:	Molecules
Sujets:	theranostics PSMA-617 prostate cancer mCRPC PET SPECT
Accès en ligne:	https://www.mdpi.com/1420-3049/28/16/6041
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!